BioFactura, Inc.

BioFactura, Inc.

BioFactura, Inc.

BioFactura develops and commercializes biodefense drugs, clientselected novel drugs, and highvalue biosimilars (i.e., followon biologics or generic biopharmaceuticals) using its patented StableFast Biomanufacturing Platform, the optimal choice for bringin
Founded
2001
Raised
$7.8M
Follow us
Alexa global traffic share
Latest funding
$6,000,000
Venture capital (Series B) - 2019
Wilson Sonsini Goodrich & Rosati The University of Vermont Health Network
$1,800,000
Venture capital (Series A) - 2016
Team Size
2
Employees
$1,800,000 Venture capital (Series A)
Venture Funding News

BioFactura Closes $1.8M Series A Funding